跳至主要内容
临床试验/NCT04766047
NCT04766047Unknown不适用

The Effect of Dexmedetomidine on the Incidence of Acute Kidney Injury in EVAR

University of Thessaly1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年8月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Incidence of Acute Kidney Injury

研究概览

简要总结

This study will investigate the effect of dexmedetomidine on the incidence of postoperative acute kidney injury in patients undergoing EVAR under general anesthesia

详细描述

This study will compare the incidence of AKI after elective EVAR conducted under general anesthesia with and without administration of dexmedetomidine. The AKI will be evaluated through measuring NGAL and c-cystatin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective EVAR under general anesthesia
  • adult patients 18- 85 years old
  • American society of anesthesiologists (ASA) physical status I - IV

排除标准

  • refusal to participate or sign the informed consent form
  • GFR < 50ml/mim
  • Bradyarrhythmia <50/min
  • Hemodynamic instability
  • Known allergy to Dexmedetomidine
  • Severe hepatic insufficiency

研究组 & 干预措施

DEXMEDETOMIDINE AND AKI

Active Comparator

The patients of the group undergoing EVAR under general anesthesia will receive dexmedetomidine intraoperatively.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Incidence of Acute Kidney Injury

时间窗: 1st Postoperative Day

Assess the incidence of Acute Kidney Injury after the administration of dexmedetomine

次要结局

  • Incidence of Postoperative Delirium(Operation day to 4th postoperative day)
  • Incidence of arrhythmia(Up to 24 hours after surgery)
  • Incidence of postoperative ICU admission(Operation day to 5th postoperative day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elena Arnaoutoglou

Professor of anesthesiology

University of Thessaly

研究点 (1)

Loading locations...

相似试验